Mounjaro is a pharmaceutical product containing tirzepatide, a synthetic peptide-based compound that acts as an agonist of both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-receptor activity has made tirzepatide an important subject of research in metabolic and endocrine science.